Table 3.
Adverse events during AD and ATAD
| DuringAD | n | % |
| URS | 7 | 10% |
| LRS | 18 | 27% |
| Dyspepsia | 13 | 19% |
| Urticaria | 5 | 7% |
| During ATAD | ||
| URS | 4 | 7% |
| LRS | 5 | 8% |
| Dyspepsia | 5 | 8% |
| Bruises, hemorrhage | 2 | 3% |
| Urticaria | 2 | 3% |
| Tinnitus | 1 | 2% |
LRS: lower respiratory symptoms, URS: upper respiratory symptoms, AD: ASA desensitization, ATAD: ASA treatment after desensitization, ASA: acetylsalicylic acid.